Literature DB >> 15277212

Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma.

Xiao-Han Chen1, Robert Siman, Akira Iwata, David F Meaney, John Q Trojanowski, Douglas H Smith.   

Abstract

Plaques composed of amyloid beta (Abeta) have been found within days following brain trauma in humans, similar to the hallmark plaque pathology of Alzheimer's disease (AD). Here, we evaluated the potential source of this Abeta and long-term mechanisms that could lead to its production. Inertial brain injury was induced in pigs via head rotational acceleration of 110 degrees over 20 ms in the coronal plane. Animals were euthanized at 3 hours, 3 days, 7 days, and 6 months post-injury. Immunohistochemistry and Western blot analyses of the brains were performed using antibodies specific for amyloid precursor protein (APP), Abeta peptides, beta-site APP-cleaving enzyme (BACE), presenilin-1 (PS-1), caspase-3, and caspase-mediated cleavage of APP (CCA). Substantial co-accumulation for all of these factors was found in swollen axons at all time points up to 6 months following injury. Western blot analysis of injured brains confirmed a substantial increase in the protein levels of these factors, particularly in the white matter. These data suggest that impaired axonal transport due to trauma induces long-term pathological co-accumulation of APP with BACE, PS-1, and activated caspase. The abnormal concentration of these factors may lead to APP proteolysis and Abeta formation within the axonal membrane compartment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15277212      PMCID: PMC1618579          DOI: 10.1016/s0002-9440(10)63303-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  78 in total

1.  Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury.

Authors:  H D Soares; R R Hicks; D Smith; T K McIntosh
Journal:  J Neurosci       Date:  1995-12       Impact factor: 6.167

2.  In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains.

Authors:  T Fernandes-Alnemri; R C Armstrong; J Krebs; S M Srinivasula; L Wang; F Bullrich; L C Fritz; J A Trapani; K J Tomaselli; G Litwack; E S Alnemri
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

3.  Amyloid beta protein 1-42/43 (A beta 1-42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study.

Authors:  A Tamaoka; N Sawamura; A Odaka; N Suzuki; H Mizusawa; S Shoji; H Mori
Journal:  Brain Res       Date:  1995-05-08       Impact factor: 3.252

4.  Mutant and native human beta-amyloid precursor proteins in transgenic mouse brain.

Authors:  D S Howland; M J Savage; F A Huntress; R E Wallace; D A Schwartz; T Loh; R H Melloni; L J DeGennaro; B D Greenberg; R Siman
Journal:  Neurobiol Aging       Date:  1995 Jul-Aug       Impact factor: 4.673

5.  Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and beta-amyloid peptide after experimental brain injury in the rat.

Authors:  J E Pierce; J Q Trojanowski; D I Graham; D H Smith; T K McIntosh
Journal:  J Neurosci       Date:  1996-02-01       Impact factor: 6.167

6.  Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide.

Authors:  B Solomon; R Koppel; E Hanan; T Katzav
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

7.  Biomechanical analysis of experimental diffuse axonal injury.

Authors:  D F Meaney; D H Smith; D I Shreiber; A C Bain; R T Miller; D T Ross; T A Gennarelli
Journal:  J Neurotrauma       Date:  1995-08       Impact factor: 5.269

8.  Head injury as a risk factor in Alzheimer's disease.

Authors:  D X Rasmusson; J Brandt; D B Martin; M F Folstein
Journal:  Brain Inj       Date:  1995-04       Impact factor: 2.311

9.  Distribution of beta-amyloid protein in the brain following severe head injury.

Authors:  D I Graham; S M Gentleman; A Lynch; G W Roberts
Journal:  Neuropathol Appl Neurobiol       Date:  1995-02       Impact factor: 8.090

10.  Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death.

Authors:  L Casciola-Rosen; D W Nicholson; T Chong; K R Rowan; N A Thornberry; D K Miller; A Rosen
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  104 in total

Review 1.  Dementia resulting from traumatic brain injury: what is the pathology?

Authors:  Sharon Shively; Ann I Scher; Daniel P Perl; Ramon Diaz-Arrastia
Journal:  Arch Neurol       Date:  2012-10

Review 2.  Association of traumatic brain injury with subsequent neurological and psychiatric disease: a meta-analysis.

Authors:  David C Perry; Virginia E Sturm; Matthew J Peterson; Carl F Pieper; Thomas Bullock; Bradley F Boeve; Bruce L Miller; Kevin M Guskiewicz; Mitchel S Berger; Joel H Kramer; Kathleen A Welsh-Bohmer
Journal:  J Neurosurg       Date:  2015-08-28       Impact factor: 5.115

Review 3.  Axonal pathology in traumatic brain injury.

Authors:  Victoria E Johnson; William Stewart; Douglas H Smith
Journal:  Exp Neurol       Date:  2012-01-20       Impact factor: 5.330

4.  Neuromechanics and Pathophysiology of Diffuse Axonal Injury in Concussion.

Authors:  Douglas H Smith
Journal:  Bridge (Wash D C)       Date:  2016-04-12

Review 5.  Traumatic brain injury, neuroinflammation, and post-traumatic headaches.

Authors:  Cynthia L Mayer; Bertrand R Huber; Elaine Peskind
Journal:  Headache       Date:  2013-07-08       Impact factor: 5.887

6.  Therapy development for diffuse axonal injury.

Authors:  Douglas H Smith; Ramona Hicks; John T Povlishock
Journal:  J Neurotrauma       Date:  2013-02-14       Impact factor: 5.269

7.  Mechanical breaking of microtubules in axons during dynamic stretch injury underlies delayed elasticity, microtubule disassembly, and axon degeneration.

Authors:  Min D Tang-Schomer; Ankur R Patel; Peter W Baas; Douglas H Smith
Journal:  FASEB J       Date:  2009-12-17       Impact factor: 5.191

Review 8.  Application and implementation of selective tissue microdissection and proteomic profiling in neurological disease.

Authors:  Jay Jagannathan; Jie Li; Nicholas Szerlip; Alexander O Vortmeyer; Russell R Lonser; Edward H Oldfield; Zhengping Zhuang
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

9.  Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans.

Authors:  Kunihiro Uryu; Xiao-Han Chen; Dan Martinez; Kevin D Browne; Victoria E Johnson; David I Graham; Virginia M-Y Lee; John Q Trojanowski; Douglas H Smith
Journal:  Exp Neurol       Date:  2007-07-10       Impact factor: 5.330

10.  Enhanced β-secretase processing alters APP axonal transport and leads to axonal defects.

Authors:  Elizabeth M Rodrigues; April M Weissmiller; Lawrence S B Goldstein
Journal:  Hum Mol Genet       Date:  2012-07-27       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.